These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7685953)
1. Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Takaya S; Bronsther O; Abu-Elmagd K; Ramos H; Fung JJ; Todo S; Starzl TE Transplant Proc; 1993 Jun; 25(3):2381-5. PubMed ID: 7685953 [No Abstract] [Full Text] [Related]
2. FK 506 treatment of intractable rejection after liver transplantation. Jost U; Winkler M; Ringe B; Rodeck B; Pichlmayr R Transplant Proc; 1993 Aug; 25(4):2686-7. PubMed ID: 7689276 [No Abstract] [Full Text] [Related]
3. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212 [No Abstract] [Full Text] [Related]
4. FK 506 as treatment of late acute rejection in liver transplant patients. Rucay P; Samuel D; Farges O; Reynes M; Bismuth H Transplant Proc; 1995 Feb; 27(1):1105-6. PubMed ID: 7533354 [No Abstract] [Full Text] [Related]
5. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J Transplant Proc; 1993 Feb; 25(1 Pt 1):679-88. PubMed ID: 7679840 [TBL] [Abstract][Full Text] [Related]
6. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. Neumann UP; Lang M; Moldenhauer A; Langrehr JM; Glanemann M; Kahl A; Frei U; Bechstein WO; Neuhaus P Transplantation; 2001 Apr; 71(8):1163-8. PubMed ID: 11374419 [TBL] [Abstract][Full Text] [Related]
7. Low incidence of chronic rejection in patients experiencing histological acute rejection without simultaneous impairment in liver function tests. Farges O; Nocci Kalil A; Sebagh M; Reynes M; Bismuth H Transplant Proc; 1995 Feb; 27(1):1142-3. PubMed ID: 7878827 [No Abstract] [Full Text] [Related]
8. Experience in one center of combined kidney and liver transplantation in 22 patients: incidence of graft rejection and long-term graft outcome. Larue JR; Hiesse C; Samuel D; Blanchet P; Bensadoun H; Benoit G; Castaing D; Adam R; Charpentier B; Bismuth H Transplant Proc; 1997; 29(1-2):243-4. PubMed ID: 9122981 [No Abstract] [Full Text] [Related]
9. Impact of immunosuppression in liver transplantation across a positive crossmatch. Lang M; Neumann U; Knoop M; Bechstein WO; Neuhaus P Transplant Proc; 1998 Jun; 30(4):1466-7. PubMed ID: 9636595 [No Abstract] [Full Text] [Related]
10. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease. Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360 [No Abstract] [Full Text] [Related]
11. Tolerance induction by liver grafting and FK 506 treatment in nonhuman primates. Gotoh M; Monden M; Kanai T; Umeshita K; Wang K; Ukei T; Dono K; Tono T; Murata M; Tanimoto J Transplant Proc; 1991 Dec; 23(6):3265-8. PubMed ID: 1721431 [No Abstract] [Full Text] [Related]
12. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279 [No Abstract] [Full Text] [Related]
13. FK 506 rescue therapy in liver transplantation: outcome and complications. McDiarmid SV; Klintmalm G; Busuttil RW Transplant Proc; 1991 Dec; 23(6):2996-9. PubMed ID: 1721339 [No Abstract] [Full Text] [Related]
14. FK 506 used as rescue therapy for refractory liver allograft rejection. Chen CL; Eng HL; Chen YS; Kuo YC; Sun CK Transplant Proc; 1994 Aug; 26(4):1927-9. PubMed ID: 7520612 [No Abstract] [Full Text] [Related]
15. Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection. Wiesner RH; Porayko MK; Wahlstrom HE; Gores GJ; Kamath PS; Hay JE; Krom RA Transplant Proc; 1993 Apr; 25(2):1791-3. PubMed ID: 7682352 [No Abstract] [Full Text] [Related]
16. Incidence and patterns of rejection using different induction therapies in liver transplant recipients. Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835 [No Abstract] [Full Text] [Related]
17. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance. Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N Clin Transpl; 2011; ():223-35. PubMed ID: 22755416 [TBL] [Abstract][Full Text] [Related]
18. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213 [No Abstract] [Full Text] [Related]
19. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related]
20. FK 506 rescue therapy for refractory acute rejection in five liver recipients. Rucay P; Samuel D; Gillet D; Bismuth H Transplant Proc; 1991 Dec; 23(6):3000-1. PubMed ID: 1721340 [No Abstract] [Full Text] [Related] [Next] [New Search]